NCT05390021 2024-04-02
PET/MRI in Endometrial Cancer
Massachusetts General Hospital
Phase NA Withdrawn
Clinical Trials
6 trialsNCT04140513 2024-03-08
Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT01789892 2018-06-28
Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT02059889 2016-12-16
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
Virginia Commonwealth University
Phase NA Withdrawn
NCT01314677 2012-06-29
Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation
City of Hope Medical Center
Phase NA Withdrawn
NCT00110006 2010-06-11
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center
Phase NA Withdrawn